(ZEUS) Olympic Steel - Overview
Stock: Steel, Aluminum, Stainless, Tubular, Processing
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.89% |
| Yield on Cost 5y | 4.40% |
| Yield CAGR 5y | 68.18% |
| Payout Consistency | 89.2% |
| Payout Ratio | 71.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 41.8% |
| Relative Tail Risk | -2.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.99 |
| Alpha | 32.57 |
| Character TTM | |
|---|---|
| Beta | 1.060 |
| Beta Downside | 0.730 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.26% |
| CAGR/Max DD | 0.08 |
Description: ZEUS Olympic Steel December 29, 2025
Olympic Steel, Inc. (NASDAQ: ZEUS) is a North-American metal processor and distributor that operates three product segments: Carbon Flat Products, Specialty Metals Flat Products, and Tubular & Pipe Products. The firm supplies a broad catalog-including stainless-steel and aluminum coils, high-strength automotive steels, coated sheet, structural tubing, boiler pipe, and tin-plate-plus a suite of value-added services such as laser cutting, beveling, and tube finishing, serving end-users in transportation, construction, mining, agriculture, energy, automotive, food service, and electrical equipment markets.
As of FY 2023, Olympic Steel reported roughly $1.1 billion in revenue with an EBITDA margin near 4.5%, and its inventory turnover sits at about 5.2 ×, reflecting relatively tight working-capital management. The company’s performance is closely tied to macro drivers like U.S. construction and infrastructure spending (which has risen ~6 % YoY following the 2023 Infrastructure Investment and Jobs Act) and steel price volatility driven by global supply constraints and tariff policy. A key sector risk is the sensitivity of demand to interest-rate-driven capital-expenditure cycles, particularly in the transportation and equipment-manufacturing segments.
For a deeper, data-driven valuation, the ValueRay platform offers granular financial metrics and scenario analysis to help you assess ZEUS’s upside potential.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 13.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.79 > 1.0 |
| NWC/Revenue: 22.00% < 20% (prev 22.14%; Δ -0.13% < -1%) |
| CFO/TA 0.07 > 3% & CFO 74.1m > Net Income 13.8m |
| Net Debt (277.3m) to EBITDA (44.4m): 6.25 < 3 |
| Current Ratio: 3.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (11.8m) vs 12m ago 0.75% < -2% |
| Gross Margin: 82.76% > 18% (prev 0.23%; Δ 8254 % > 0.5%) |
| Asset Turnover: 180.7% > 50% (prev 198.8%; Δ -18.18% > 0%) |
| Interest Coverage Ratio: 2.14 > 6 (EBITDA TTM 44.4m / Interest Expense TTM 16.5m) |
Altman Z'' 5.24
| A: 0.38 (Total Current Assets 614.7m - Total Current Liabilities 196.9m) / Total Assets 1.09b |
| B: 0.40 (Retained Earnings 439.7m / Total Assets 1.09b) |
| C: 0.03 (EBIT TTM 35.2m / Avg Total Assets 1.05b) |
| D: 1.13 (Book Value of Equity 579.1m / Total Liabilities 510.9m) |
| Altman-Z'' Score: 5.24 = AAA |
Beneish M -3.50
| DSRI: 1.12 (Receivables 209.7m/197.6m, Revenue 1.90b/2.01b) |
| GMI: 0.28 (GM 82.76% / 22.83%) |
| AQI: 1.30 (AQ_t 0.21 / AQ_t-1 0.16) |
| SGI: 0.94 (Revenue 1.90b / 2.01b) |
| TATA: -0.06 (NI 13.8m - CFO 74.1m) / TA 1.09b) |
| Beneish M-Score: -3.50 (Cap -4..+1) = AA |
What is the price of ZEUS shares?
Over the past week, the price has changed by +6.34%, over one month by +14.08%, over three months by +49.23% and over the past year by +48.78%.
Is ZEUS a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ZEUS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 38 | -25.7% |
| Analysts Target Price | 38 | -25.7% |
| ValueRay Target Price | 55.7 | 8.9% |
ZEUS Fundamental Data Overview February 03, 2026
P/E Forward = 13.1234
P/S = 0.2962
P/B = 0.9352
P/EG = 0.46
Revenue TTM = 1.90b USD
EBIT TTM = 35.2m USD
EBITDA TTM = 44.4m USD
Long Term Debt = 240.9m USD (from longTermDebt, last quarter)
Short Term Debt = 7.55m USD (from shortTermDebt, last quarter)
Debt = 284.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 277.3m USD (from netDebt column, last quarter)
Enterprise Value = 839.7m USD (562.4m + Debt 284.9m - CCE 7.55m)
Interest Coverage Ratio = 2.14 (Ebit TTM 35.2m / Interest Expense TTM 16.5m)
EV/FCF = 20.03x (Enterprise Value 839.7m / FCF TTM 41.9m)
FCF Yield = 4.99% (FCF TTM 41.9m / Enterprise Value 839.7m)
FCF Margin = 2.21% (FCF TTM 41.9m / Revenue TTM 1.90b)
Net Margin = 0.73% (Net Income TTM 13.8m / Revenue TTM 1.90b)
Gross Margin = 82.76% ((Revenue TTM 1.90b - Cost of Revenue TTM 327.3m) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.77 (Enterprise Value 839.7m / Total Assets 1.09b)
Interest Expense / Debt = 1.42% (Interest Expense 4.05m / Debt 284.9m)
Taxrate = 30.65% (952.0k / 3.11m)
NOPAT = 24.4m (EBIT 35.2m * (1 - 30.65%))
Current Ratio = 3.12 (Total Current Assets 614.7m / Total Current Liabilities 196.9m)
Debt / Equity = 0.49 (Debt 284.9m / totalStockholderEquity, last quarter 579.1m)
Debt / EBITDA = 6.25 (Net Debt 277.3m / EBITDA 44.4m)
Debt / FCF = 6.62 (Net Debt 277.3m / FCF TTM 41.9m)
Total Stockholder Equity = 576.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.31% (Net Income 13.8m / Total Assets 1.09b)
RoE = 2.39% (Net Income TTM 13.8m / Total Stockholder Equity 576.4m)
RoCE = 4.31% (EBIT 35.2m / Capital Employed (Equity 576.4m + L.T.Debt 240.9m))
RoIC = 2.97% (NOPAT 24.4m / Invested Capital 821.8m)
WACC = 6.85% (E(562.4m)/V(847.3m) * Re(9.82%) + D(284.9m)/V(847.3m) * Rd(1.42%) * (1-Tc(0.31)))
Discount Rate = 9.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.75%
[DCF Debug] Terminal Value 75.78% ; FCFF base≈43.9m ; Y1≈28.8m ; Y5≈13.2m
Fair Price DCF = 4.20 (EV 324.6m - Net Debt 277.3m = Equity 47.3m / Shares 11.3m; r=6.85% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -80.72 | EPS CAGR: -64.90% | SUE: -0.55 | # QB: 0
Revenue Correlation: -83.24 | Revenue CAGR: -6.23% | SUE: 0.64 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.78 | Chg30d=+0.150 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.28 | Chg30d=-0.015 | Revisions Net=-1 | Growth EPS=+132.7% | Growth Revenue=+3.1%